| |
| |
|
| Insider
Information: |
Muehl Daniel W |
| Relationship: |
See Remarks |
| City: |
North Billerca |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
114,830 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,483,372 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
114,830 |
|
|
| Total
Value |
$1,483,372 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
26
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
23
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -1,216.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Repligen Corp |
RGEN |
CFO |
2006-01-19 |
10,000 |
2006-01-19 |
0 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2022-11-02 |
104,830 |
2017-03-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-03-01 |
4 |
D |
$55.51 |
$14,377 |
D/D |
(259) |
2,904 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-08-03 |
4 |
S |
$5.92 |
$14,836 |
D/D |
(2,506) |
30,172 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2017-11-29 |
4 |
D |
$59.49 |
$15,408 |
D/D |
(259) |
2,616 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-05-05 |
4 |
S |
$8.10 |
$17,925 |
D/D |
(2,213) |
26,194 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2022-03-02 |
4 |
S |
$1.87 |
$19,977 |
D/D |
(10,706) |
82,324 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2021-11-02 |
4 |
S |
$4.55 |
$20,580 |
D/D |
(4,523) |
67,089 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2021-08-03 |
4 |
S |
$4.82 |
$21,724 |
D/D |
(4,507) |
61,050 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2017-03-08 |
4 |
D |
$59.27 |
$23,708 |
D/D |
(400) |
850 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2021-05-04 |
4 |
S |
$5.54 |
$26,797 |
D/D |
(4,837) |
54,977 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-03-05 |
4 |
S |
$29.29 |
$37,989 |
D/D |
(1,297) |
7,367 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2018-03-07 |
4 |
D |
$58.43 |
$48,263 |
D/D |
(826) |
3,953 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2017-08-25 |
4 |
D |
$73.16 |
$51,212 |
D/D |
(700) |
2,338 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2017-08-29 |
4/A |
D |
$72.14 |
$51,219 |
D/D |
(710) |
2,328 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-02-04 |
4 |
S |
$8.41 |
$88,070 |
D/D |
(10,472) |
21,959 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2021-02-02 |
4 |
S |
$7.97 |
$94,620 |
D/D |
(11,872) |
46,990 |
0 |
% |
|
90 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
